We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Medications for Weight Loss: Indications and Usage FREE

Jill Jin, MD, MPH
JAMA. 2015;313(21):2196. doi:10.1001/jama.2015.5575.
Text Size: A A A
Published online

Medications can help with weight loss in certain groups of people, but there is no “magic” pill.

Medications for weight loss work best when combined with a lifestyle treatment program, and such medications require close monitoring by a doctor.


Lifestyle approaches to help people who are overweight or obese follow a healthy reduced-calorie diet and increase their physical activity are always the first and most important steps in treating obesity. Unfortunately, for many people it is difficult to lose weight and even harder to maintain weight loss. More than 1 of 3 Americans today are obese, which is defined as having a body mass index (BMI) of 30 or higher.

Medications are sometimes used to help with weight loss in people who are obese and who have not been able to lose weight or maintain weight loss with diet, exercise, or behavioral treatment. Sometimes, weight loss medications are prescribed for people with a BMI of between 27 and 30 if they have other health problems such as diabetes, high cholesterol, heart disease, high blood pressure, or obstructive sleep apnea. Using the medications along with lifestyle treatment improves weight loss outcomes.


There are several medications approved by the US Food and Drug Administration for long-term treatment (more than 3 months). These medications all have side effects, so they need to be closely monitored by a doctor. In general, if a patient does not lose at least 5% of his or her starting weight after taking a full dose of the medication for 3 months, that medication should be stopped, and the doctor should decide what other types of treatment may be helpful. The medications approved for long-term treatment may lead to improvements in some risk factors for heart disease or diabetes, but some of the medications increase pulse or blood pressure and should be used with caution in patients with a history of heart disease. No obesity medication has been shown to lower risk of developing heart disease or stroke. Obesity medications should not be used by women who are pregnant or planning to become pregnant.


It is important to have realistic expectations when starting a weight loss medication. The amount of weight loss is less than what many people expect—about 5% to 10% of the starting weight on average. However, people vary in their response, with some people losing less weight and others losing much more. Like other medications taken for chronic conditions such as high blood pressure, obesity medications do not work after they are stopped, so gradual weight regain is likely after discontinuing the drug. Ask your doctor if you have questions about whether a weight loss medication may be right for you.

In a second Patient Page on medications for weight loss, specific medications will be discussed.

Box Section Ref ID

For More Information

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA’s website at jama.com. Many are available in English and Spanish.


The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

Sources: Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014;311(1):74-86.

Wadden TA, Butryn ML, Hong PS, Tsai AG. Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review. JAMA. 2014;312(17):1779-1791.

Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342-362.

Topic: Endocrinology and Metabolism




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Spanish Patient Page: Medicamentos para la prédida de peso: Indicaciones y uso:

Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Promoción de la salud en el ciclo de vida